T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Macerich
MAC
$6.94B
| $327M | 0.07% |
3,923,148
-61,390
| -2% | -$4.52M |
|
327
Newmont
NEM
$125B
| $326M | 0.07% |
17,273,433
+1,733,900
| +11% | +$34.9M |
|
|
POT
328
DELISTED
Potash Corp Of Saskatchewan
POT
| $326M | 0.07% |
9,223,829
+1,187,430
| +15% | +$40.4M |
|
329
Pricesmart
PSMT
$5.48B
| $325M | 0.07% |
3,566,437
+285,528
| +9% | +$25.8M |
|
330
Intel
INTC
$516B
| $324M | 0.07% |
8,920,758
+93,009
| +1% | +$3.24M |
|
|
ATML
331
DELISTED
ATMEL CORP
ATML
| $319M | 0.07% |
38,052,283
+1,660,353
| +5% | +$12.7M |
|
332
Five Below
FIVE
$13.2B
| $319M | 0.07% |
7,817,010
+267,666
| +4% | +$10.8M |
|
|
MINI
333
DELISTED
Mobile Mini Inc
MINI
| $312M | 0.07% |
7,708,056
+51,150
| +0.7% | +$2.07M |
|
|
CA
334
DELISTED
CA, Inc.
CA
| $312M | 0.07% |
10,247,275
+5,876,973
| +134% | +$172M |
|
335
Landstar System
LSTR
$6.31B
| $310M | 0.07% |
4,275,419
-487,321
| -10% | -$36.2M |
|
|
AVP
336
DELISTED
Avon Products, Inc.
AVP
| $309M | 0.07% |
32,886,450
-14,068,113
| -30% | -$145M |
|
|
WCG
337
DELISTED
Wellcare Health Plans, Inc.
WCG
| $308M | 0.07% |
3,755,589
+2,385,389
| +174% | +$166M |
|
338
Lumen
LUMN
$6.58B
| $307M | 0.07% |
7,756,481
+25,410
| +0.3% | +$1.02M |
|
|
WPX
339
DELISTED
WPX Energy, Inc.
WPX
| $305M | 0.06% |
26,240,573
-2,213,781
| -8% | -$35.3M |
|
340
Sun Life Financial
SLF
$44.4B
| $304M | 0.06% |
8,414,000
+461,700
| +6% | +$16.5M |
|
341
Lennox International
LII
$14.6B
| $304M | 0.06% |
3,193,940
+761,150
| +31% | +$67.6M |
|
342
Wolverine World Wide
WWW
$1.48B
| $303M | 0.06% |
10,271,021
+282,161
| +3% | +$7.82M |
|
343
Eaton
ETN
$180B
| $302M | 0.06% |
4,442,125
-206,516
| -4% | -$13.6M |
|
|
MON
344
DELISTED
Monsanto Co
MON
| $300M | 0.06% |
2,514,016
-346,307
| -12% | -$40.2M |
|
345
SL Green Realty
SLG
$4B
| $300M | 0.06% |
2,602,227
-16,791
| -0.6% | -$1.86M |
|
|
SAPE
346
DELISTED
SAPIENT CORP
SAPE
| $300M | 0.06% |
12,040,971
-835,810
| -6% | -$17.6M |
|
347
First Horizon
FHN
$12.3B
| $299M | 0.06% |
22,041,971
+67,489
| +0.3% | +$855K |
|
348
Akamai
AKAM
$17.8B
| $296M | 0.06% |
4,698,699
-4,216,664
| -47% | -$254M |
|
349
Digital Realty Trust
DLR
$72.7B
| $295M | 0.06% |
4,443,505
-37,526
| -0.8% | -$2.51M |
|
350
Masco
MAS
$14.7B
| $294M | 0.06% |
13,277,352
+41,093
| +0.3% | +$849K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.